Grants per year
Personal profile
Research Interests
I am an Assistant Professor of Urology at the Northwestern University Feinberg School of Medicine, as well as Section Chief of Robotic Surgery at the Jesse Brown VA Medical Center. I received his MD and PhD degrees from Northwestern University in 2005, completed my urology residency at Northwestern University in 2011, and a urologic oncology fellowship at Memorial Sloan-Kettering Cancer in 2012. My clinical efforts focus on minimally invasive and open urologic oncology with a particular interest in bladder and prostate cancer. My research interests focus on both the epigenetics and genetic mutations associated with cancer biology. Specifically,I am studying how chromatin remodeling genes play a role in bladder cancer. In addition, I am studying the “driver” mutations found in bladder cancer. In the future, I hope to develop novel systemic and intravesical therapies to improve survival of patients with bladder cancer.
Certifications and Licenses
| Urology |
Training Experience
| 2006 | Internship, Northwestern University, Feinberg School of Medicine |
| 2011 | Residency, Northwestern University, Feinberg School of Medicine |
| 2012 | Fellowship, Memorial Sloan-Kettering Cancer Center |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, Northwestern University
… → 2005
Cell Biology, PhD, Northwestern University
… → 2003
Research interests
- Big Data
- Bioinformatics
- Bladder Cancer
- Bladder and Urinary Tract
- Genetics
- Immunogenetics
- Immunology
- Oncology
- Robotic Surgery
- Translational Research
- Urology
Fingerprint
Dive into the research topics where Joshua J Meeks is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Prot #MK-3475-676: A Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette- Guerin (BCG) in Participants with High-risk Non-muscle Invasive Bladder Cance
Merck Sharp & Dohme Corporation
4/18/22 → 4/18/25
Project: Research project
-
-
Prot #42756493BLC2003: A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Subjects Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) and FGF
Janssen Research & Development, LLC
8/6/21 → 9/11/26
Project: Research project
-
Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy
Podojil, J. R., Cogswell, A. C., Chiang, M. Y., Eaton, V., Ifergan, I., Neef, T., Xu, D., Meghani, K. A., Yu, Y., Orbach, S. M., Murthy, T., Boyne, M. T., Elhofy, A., Shea, L. D., Meeks, J. J. & Miller, S. D., Aug 18 2022, In: Frontiers in immunology. 13, 887649.Research output: Contribution to journal › Article › peer-review
Open Access -
Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))
Robertson, A. G., Groeneveld, C. S., Jordan, B., Lin, X., McLaughlin, K. A., Das, A., Fall, L. A., Fantini, D., Taxter, T. J., Mogil, L. S., Lindskrog, S. V., Dyrskjøt, L., McConkey, D. J., Svatek, R. S., de Reyniès, A., Castro, M. A. A. & Meeks, J. J., Feb 2022, In: European urology. 81, 2, p. e53Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study
IDENTIFY Study group, 2022, (Accepted/In press) In: European Urology Focus.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin
Meghani, K., Cooley, L. F., Choy, B., Kocherginsky, M. N., Swaminathan, S., Munir, S. S., Svatek, R. S., Kuzel, T. M. & Meeks, J. J., 2022, (Accepted/In press) In: European urology.Research output: Contribution to journal › Article › peer-review
Open Access -
Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer
Cooley, L. F., Glaser, A. P. & Meeks, J. J., Jul 2022, In: Urologic Oncology: Seminars and Original Investigations. 40, 7, p. 279-286 8 p.Research output: Contribution to journal › Review article › peer-review
4 Scopus citations